Schedule 13G ownership disclosure

ADAMAS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00548A106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,735,309
Percent of class
6.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000834237-20-004693
Form type
SC 13G/A
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Feb 05, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub